351 related articles for article (PubMed ID: 26035167)
1. Clinical Relevance of Kynurenine Pathway in HIV/AIDS: An Immune Checkpoint at the Crossroads of Metabolism and Inflammation.
Routy JP; Mehraj V; Vyboh K; Cao W; Kema I; Jenabian MA
AIDS Rev; 2015; 17(2):96-106. PubMed ID: 26035167
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.
Favre D; Mold J; Hunt PW; Kanwar B; Loke P; Seu L; Barbour JD; Lowe MM; Jayawardene A; Aweeka F; Huang Y; Douek DC; Brenchley JM; Martin JN; Hecht FM; Deeks SG; McCune JM
Sci Transl Med; 2010 May; 2(32):32ra36. PubMed ID: 20484731
[TBL] [Abstract][Full Text] [Related]
3. The end of the road for the tryptophan depletion concept in pregnancy and infection.
Badawy AA; Namboodiri AM; Moffett JR
Clin Sci (Lond); 2016 Aug; 130(15):1327-33. PubMed ID: 27358028
[TBL] [Abstract][Full Text] [Related]
4. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
Bipath P; Levay PF; Viljoen M
BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.
Jenabian MA; El-Far M; Vyboh K; Kema I; Costiniuk CT; Thomas R; Baril JG; LeBlanc R; Kanagaratham C; Radzioch D; Allam O; Ahmad A; Lebouché B; Tremblay C; Ancuta P; Routy JP;
J Infect Dis; 2015 Aug; 212(3):355-66. PubMed ID: 25616404
[TBL] [Abstract][Full Text] [Related]
6. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
Neurauter G; Zangerle R; Widner B; Quirchmair G; Sarcletti M; Fuchs D
Adv Exp Med Biol; 2003; 527():317-23. PubMed ID: 15206745
[TBL] [Abstract][Full Text] [Related]
7. Host genetic predictors of the kynurenine pathway of tryptophan catabolism among treated HIV-infected Ugandans.
Lee SA; Mefford JA; Huang Y; Witte JS; Martin JN; Haas DW; Mclaren PJ; Mushiroda T; Kubo M; Byakwaga H; Hunt PW; Kroetz DL
AIDS; 2016 Jul; 30(11):1807-15. PubMed ID: 27088321
[TBL] [Abstract][Full Text] [Related]
8. Role of tryptophan metabolism in cancers and therapeutic implications.
Liu XH; Zhai XY
Biochimie; 2021 Mar; 182():131-139. PubMed ID: 33460767
[TBL] [Abstract][Full Text] [Related]
9. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.
Byakwaga H; Boum Y; Huang Y; Muzoora C; Kembabazi A; Weiser SD; Bennett J; Cao H; Haberer JE; Deeks SG; Bangsberg DR; McCune JM; Martin JN; Hunt PW
J Infect Dis; 2014 Aug; 210(3):383-91. PubMed ID: 24585899
[TBL] [Abstract][Full Text] [Related]
10. Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans.
Martinez P; Tsai AC; Muzoora C; Kembabazi A; Weiser SD; Huang Y; Haberer JE; Martin JN; Bangsberg DR; Hunt PW
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):456-62. PubMed ID: 24220289
[TBL] [Abstract][Full Text] [Related]
11. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection.
Zangerle R; Widner B; Quirchmair G; Neurauter G; Sarcletti M; Fuchs D
Clin Immunol; 2002 Sep; 104(3):242-7. PubMed ID: 12217334
[TBL] [Abstract][Full Text] [Related]
12. Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain.
Wu W; Nicolazzo JA; Wen L; Chung R; Stankovic R; Bao SS; Lim CK; Brew BJ; Cullen KM; Guillemin GJ
PLoS One; 2013; 8(4):e59749. PubMed ID: 23630570
[TBL] [Abstract][Full Text] [Related]
13. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection.
Cunningham-Rundles S; Ahrné S; Johann-Liang R; Abuav R; Dunn-Navarra AM; Grassey C; Bengmark S; Cervia JS
Nutrients; 2011 Dec; 3(12):1042-70. PubMed ID: 22292110
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
Kim M; Tomek P
Front Immunol; 2021; 12():636081. PubMed ID: 33708223
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases.
Boros FA; Bohár Z; Vécsei L
Mutat Res Rev Mutat Res; 2018; 776():32-45. PubMed ID: 29807576
[TBL] [Abstract][Full Text] [Related]
16. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
[TBL] [Abstract][Full Text] [Related]
17. A highly efficient modality to block the degradation of tryptophan for cancer immunotherapy: locked nucleic acid-modified antisense oligonucleotides to inhibit human indoleamine 2,3-dioxygenase 1/tryptophan 2,3-dioxygenase expression.
Klar R; Michel S; Schell M; Hinterwimmer L; Zippelius A; Jaschinski F
Cancer Immunol Immunother; 2020 Jan; 69(1):57-67. PubMed ID: 31802183
[TBL] [Abstract][Full Text] [Related]
18. Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions.
Strasser B; Becker K; Fuchs D; Gostner JM
Neuropharmacology; 2017 Jan; 112(Pt B):286-296. PubMed ID: 26924709
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.
Terness P; Bauer TM; Röse L; Dufter C; Watzlik A; Simon H; Opelz G
J Exp Med; 2002 Aug; 196(4):447-57. PubMed ID: 12186837
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus type 1 clade B and C Tat differentially induce indoleamine 2,3-dioxygenase and serotonin in immature dendritic cells: Implications for neuroAIDS.
Samikkannu T; Rao KV; Gandhi N; Saxena SK; Nair MP
J Neurovirol; 2010 Jul; 16(4):255-63. PubMed ID: 20602605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
